dmt use and clinical characteristics in ms by race and ethnicity
Published 3 years ago • 188 plays • Length 1:39Download video MP4
Download video MP3
Similar videos
-
0:47
when to make a timely switch to high-efficacy dmt for ms
-
3:19
chariotms: the first dmt trial in advanced multiple sclerosis
-
2:12
early initiation of high-efficacy dmts in ms
-
2:11
when should dmts be stopped when treating ms?
-
1:33
the demographics of ms in latin america
-
2:42
cladribine treatment patterns in ms patients: a cross-sectional survey
-
1:04
what’s to come in the ms field?
-
50:36
race, ethnicity, and clinical utility in cancer genetics | webinar | ambry genetics
-
1:59
2-minute neuroscience: dmt
-
0:24
dmt: does dmt have side effects?
-
0:23
dmt: what happens when you take dmt?
-
22:48
aphg.4.1- how do gender, ethnicity, and race influence identity?
-
2:09
differential impacts of covid-19 across racial-ethnic identities in persons with opioid use disorder
-
2:13
race and ethnicity
-
21:38
aphg unit 3 (race, ethinicity, gender, and identity) review (2015-2016)
-
25:15
online lecture race and ethnicity in politics
-
4:19
race and ethnicity in the media
-
15:01
race and racism in society
-
11:57
dmt and the psychedelic renaissance | nick glynos | tedxuofm